NASDAQ$RCEL

AVITA Medical Inc · Q1 2019 earnings

Q1 2019 earnings · · Investor relations

Headline financials

Total Revenue

$269K

No prior period
EPS (adj)

-$0.00

No prior period
Net Income

-$5.03M

No prior period
Operating Income

-$5.06M

No prior period
Gross Profit

$37K

No prior period
Stock-Based Comp

$217K

No prior period

Revenue & EPS history

AVITA Medical · Revenue · Quarterly

$269K

Q1 2019
Beat estimate in 1 of 7 quarters(14%)
ActualEstimate

Revenue by segment

AVITA Medical · $19.3M total across 2 segments · Q1 2026

  • Sales Revenue
    $19.1M
  • Lease Revenue
    $187K

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2019

Historical avgQ1 2019

+3.8%

Avg return

Earnings day

+4.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

57%

17 / 30 earnings

Positive

+36.7%

Q4 2022

Best reaction

-25.1%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-0.5%-10.1%
Q4 2025+11.8%+15.9%+18.3%
Q3 2025+10.6%+11.2%+2.9%
Q2 2025-21.2%+7.1%-20.8%
Q1 2025-25.1%-28.3%-34.5%
Q4 2024+20.4%+16.4%-2.6%
Q3 2024-2.0%+3.9%+7.3%
Q2 2024+19.6%+20.1%+10.5%
Q1 2024+5.6%+0.1%+7.1%
Q4 2023-1.7%+5.2%-9.8%
Q3 2023+9.2%+29.9%+32.0%
Q2 2023+2.5%-2.1%-12.0%
Q1 2023-24.5%-24.2%+6.8%
Q4 2022+36.7%+48.2%+41.9%
Q3 2022+28.9%+39.0%+22.1%
Q2 2022-7.1%-8.7%-17.8%
Q1 2022+9.4%+10.1%+8.6%
Q4 2021+17.1%+8.2%-5.2%
Q3 2021+3.5%-10.7%-4.6%
Q3 2020+3.5%-10.7%-4.6%
Q2 2021-4.1%-5.3%-15.0%
Q1 2021-5.4%-6.4%-9.6%
Q1 2020-5.4%-6.4%-9.6%
Q2 2020+10.2%+5.8%-0.8%
Q3 2019+10.2%+9.5%+6.2%
Q4 2020+10.2%+9.5%+6.2%
Q1 2019+10.2%+9.5%+6.2%
Q4 2019-2.5%-1.9%+11.4%
Q4 2018-2.5%-1.9%+11.4%
Q2 2019-2.5%-1.9%+11.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro